HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Immunoblot analysis of sera from Ethiopian cutaneous leishmaniasis by antibody class.

Abstract
We have determined the specificity of the classes of anti-leishmanial antibodies which are detectable in serum from patients with active cutaneous leishmaniasis. On immunoblots, differences exist in the patterns of antigen recognition by IgG, IgM, IgA and IgE antibodies present in localized cutaneous leishmaniasis (LCL) and diffuse cutaneous leishmaniasis (DCL) patient serum. Each class of antibody showed differing patterns of banding to the various molecular species of parasite antigens. There was significant variation in the specificities of the IgG antibody reactivities between individual patients. The patterns of IgM binding were generally homogeneous and restricted to antigens with M(r) greater than 40 kDa. The only class of anti-Leishmania antibodies which showed shared patterns of common antigen recognition by all of the patients studied were IgA antibodies. The reactivities of IgE antibodies encompassed two antigens of M(r) 36 and 46-48 kDa which were not recognized by any of the other isotypes. Such antibody class associated reactivity may be useful in the design of serodiagnostic assays for the detection of Leishmania infection or other infectious agents.
AuthorsG Mengistu, H Akuffo, T E Fehniger
JournalScandinavian journal of immunology. Supplement (Scand J Immunol Suppl) Vol. 11 Pg. 149-52 ( 1992) ISSN: 0301-6323 [Print] England
PMID1514031 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Protozoan
  • Immunoglobulin A
  • Immunoglobulin G
Topics
  • Antibodies, Protozoan (analysis)
  • Ethiopia
  • Female
  • Humans
  • Immunoblotting
  • Immunoglobulin A (analysis)
  • Immunoglobulin G (analysis)
  • Leishmaniasis, Cutaneous (immunology)
  • Male
  • Molecular Weight

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: